0001645113-22-000023.txt : 20220307
0001645113-22-000023.hdr.sgml : 20220307
20220307182825
ACCESSION NUMBER: 0001645113-22-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220303
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longsworth Todd Christopher
CENTRAL INDEX KEY: 0001693530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 22719724
MAIL ADDRESS:
STREET 1: NOVOCURE, 20 VALLEY STREAM PARKWAY
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_164669568882280.xml
FORM 4
X0306
4
2022-03-03
0
0001645113
NovoCure Ltd
NVCR
0001693530
Longsworth Todd Christopher
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
General Counsel
Ordinary Shares
2022-03-03
4
S
0
1094
74.498
D
66774
D
Ordinary Shares
2022-03-04
4
S
0
1973
70.407
D
64801
D
Options to Buy Ordinary Shares
80.59
2022-03-03
4
A
0
6106
80.59
A
2023-03-01
2032-02-29
Ordinary Shares
6106.0
6106
D
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Options to buy 6,106 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.
By: /s/ Steven Robbins, Attorney in Fact for Todd Longsworth
2022-03-07